Cargando…
Loss of lncRNA MIAT ameliorates proliferation and fibrosis of diabetic nephropathy through reducing E2F3 expression
Diabetic nephropathy (DN) is a serious kidney disease resulted from diabetes. Dys‐regulated proliferation and extracellular matrix (ECM) accumulation in mesangial cells contribute to DN progression. In this study, we tested expression level of MIAT in DN patients and mesangial cells treated by high...
Autores principales: | Ji, Ting‐Ting, Qi, Ying‐Hui, Li, Xiao‐Ying, Tang, Bo, Wang, Ya‐Kun, Zheng, Peng‐Xi, Li, Weiliang, Qu, Xiaolei, Feng, Linhong, Bai, Shou‐Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7701586/ https://www.ncbi.nlm.nih.gov/pubmed/33009725 http://dx.doi.org/10.1111/jcmm.15949 |
Ejemplares similares
-
Inhibition of the lncRNA MIAT prevents podocyte injury and mitotic catastrophe in diabetic nephropathy
por: Wang, Ziyang, et al.
Publicado: (2022) -
Downregulation of lncRNA Miat contributes to the protective effect of electroacupuncture against myocardial fibrosis
por: Qi, Wenchuan, et al.
Publicado: (2022) -
Elevated lncRNA MIAT in peripheral blood mononuclear cells contributes to post-menopausal osteoporosis
por: Li, Rui, et al.
Publicado: (2022) -
Ablation of lncRNA Miat attenuates pathological hypertrophy and heart failure
por: Yang, Liu, et al.
Publicado: (2021) -
LncRNA-MIAT Increased in Patients with Coronary Atherosclerotic Heart Disease
por: Tan, Jin, et al.
Publicado: (2019)